Cohance Lifesciences Limited CC-Dec24.pdf · 2025-02-12
Hi, thank you for the opportunity and congrats on good set of numbers. First one on our long- term guidance that we have put out on billion- dollar kind of revenue by FY'30. I would like to understand when do we start seeing that kind of acceleration in our topline? While we are seeing that in Q3, but on a 9-month basis, we are still at low growth because of issues in Spec Chem business, etc. So, is it more, let's say in a near term, where we should see the acceleration or let's say it is part of the timeline range, how should we think about it?
And sir for this traction to happen, or whatever, you have built in, the potential projects that we might need to execute for that traction, would you say they are already more or less in place? And then it would not build a lot of new project expectation? How is your expectation there?